|
| 37315390 | Wild-Type Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer. | | 2023 |
| 36230811 | Defining A Liquid Biopsy Profile of Circulating Tumor Cells and Oncosomes in Metastatic Colorectal Cancer for Clinical Utility. | Cancers (Basel) | 2022 |
| 31611341 | Risk factors for disease progression in idiopathic pulmonary fibrosis. | Thorax | 2020 |
| 27939076 | Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial. | Lancet Respiratory Medicine,The | 2017 |
| 26573425 | RAS testing in metastatic colorectal cancer: advances in Europe. | Virchows Archiv | 2016 |
| 26719571 | Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays. | Clin Chem | 2016 |
| 26849815 | The State of the Art in Colorectal Cancer Molecular Biomarker Testing. | Advances in Anatomic Pathology | 2016 |
| 26341920 | Analysis of KRAS/NRAS Mutations in a Phase III Study of Panitumumab with FOLFIRI Compared with FOLFIRI Alone as Second-line Treatment for Metastatic Colorectal Cancer. | Clinical Cancer Research | 2015 |
| 25376580 | Biomarkers in the pharmaceutical industry. | Clinical Chemistry | 2015 |
| 25583476 | Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy. | Proc Natl Acad Sci U S A | 2015 |
| 25807104 | Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues. | PLoS ONE | 2015 |
| 25314641 | Challenges in developing a validated biomarker for angiogenesis inhibitors: the motesanib experience. | PLoS ONE | 2014 |
| 23325582 | Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer. | Clinical Cancer Research | 2013 |
| 24024839 | Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. | New England Journal of Medicine | 2013 |
| 23741071 | Putative predictive biomarkers of survival in patients with metastatic pancreatic adenocarcinoma treated with gemcitabine and ganitumab, an IGF1R inhibitor. | Clinical Cancer Research | 2013 |
| 23250354 | Guideline on the requirements of external quality assessment programs in molecular pathology. | Virchows Arch | 2013 |
| 21787188 | Prospective-retrospective biomarker analysis for regulatory consideration: white paper from the industry pharmacogenomics working group. | Pharmacogenomics | 2011 |
| 21448748 | Translational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop. | AAPS J | 2011 |
| 20663962 | Evidence for endotoxin contamination in plastic Na+-heparin blood collection tube lots. | Clinical Chemistry | 2010 |
| 21179889 | Report from the Wellcome Trust/EBA â¿¿Perspectives in Clinical Proteomicsâ¿ retreat--a strategy to implement next-generation proteomic analyses to the clinic for patient benefit: pathway to translation. | Proteomics Clin Appl | 2010 |
| 20398393 | A comparability study of 5 commercial KRAS tests. | Diagnostic Pathology | 2010 |
| 20032635 | KRAS mutation testing in human cancers: The pathologist's role in the era of personalized medicine. | Advances in Anatomic Pathology | 2010 |
| 20101609 | Maximizing the sensitivity and reliability of peptide identification in large-scale proteomic experiments by harnessing multiple search engines. | Proteomics | 2010 |
| 19959624 | Cancer biomarker discovery via low molecular weight serum profiling--are we following circular paths? | Clinical Chemistry | 2010 |
| 19902637 | HHS issues Interim Final Rule on health data breaches. | Delaware medical journal | 2009 |
| 19131327 | A human proteome detection and quantitation project. | Mol Cell Proteomics | 2009 |
| 19253279 | Quantifying proteins by mass spectrometry: the selectivity of SRM is only part of the problem. | Proteomics | 2009 |
| 18688232 | Guidelines for reporting the use of mass spectrometry in proteomics. | Nat Biotechnol | 2008 |
| 18474044 | The evolution of tools for protein phosphorylation site analysis: from discovery to clinical application. | BioTechniques | 2008 |
| 18316791 | Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. | Journal of Clinical Oncology | 2008 |
| 17249495 | Does the serum peptidome reveal hemostatic dysregulation? | Ernst Schering Research Foundation workshop | 2007 |
| 21136654 | Cancer biomarker discovery via low molecular weight serum proteome profiling - Where is the tumor? | Proteomics - Clinical Applications | 2007 |
| 17687369 | The minimum information about a proteomics experiment (MIAPE). | Nat Biotechnol | 2007 |
| 16400714 | Guidelines for the next 10 years of proteomics. | Proteomics | 2006 |
| 23495841 | The role of biomarkers in the future of drug development. | Expert Opinion on Drug Discovery | 2006 |
| 17139572 | A strategic view on the use of pharmacodynamic biomarkers in early clinical drug development. | IDrugs : the investigational drugs journal | 2006 |
| 15722219 | Informatics for protein identification by mass spectrometry. | Methods | 2005 |
| 14998538 | Quantitation of phosphopeptides using affinity chromatography and stable isotope labeling. | Journal of the American Society for Mass Spectrometry | 2004 |
| 15593199 | Proteomics: beginning to realize its promise? | | 2004 |
| 15580857 | [From genome to proteome--aim of human proteomics]. | Seikagaku | 2004 |
| 15169873 | Proteomic analysis of interchromatin granule clusters. | Molecular Biology of the Cell | 2004 |
| 14513544 | Proteomics: evolution of the technology. | BioTechniques | 2003 |
| 12610558 | Data analysis--the Achilles heel of proteomics. | Nature Biotechnology | 2003 |
| 12610541 | Proteomics: the first decade and beyond. | Nat Genet | 2003 |
| 12596360 | Enabling parallel protein analysis through mass spectrometry. | Current Opinion in Molecular Therapeutics | 2002 |
| 12570160 | Proteomics: drug target discovery on an industrial scale. | Trends in Biotechnology | 2002 |
| 11270867 | Automated LC-LC-MS-MS platform using binary ion-exchange and gradient reversed-phase chromatography for improved proteomic analyses. | | 2001 |
| 18265063 | Protein identification and characterization by mass spectrometry. | Current Protocols in Molecular Biology | 2001 |
| 11683508 | Mass spectrometry of proteomics. | Proteomics | 2001 |
| 11680902 | Towards defining the urinary proteome using liquid chromatography-tandem mass spectrometry. I. Profiling an unfractionated tryptic digest. | Proteomics | 2001 |